A Prospective, Randomized, Controlled Trial of Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma
Weiping Zhou(Shenyang Medical College), Meng-Chao Wu(Second Military Medical University), Eric C. H. Lai(Second Military Medical University), Aijun Li(Second Military Medical University), Jianping Zhou(Shenyang Medical College), Ze‐Ya Pan(Second Military Medical University), Siyuan Fu(Nanjing University of Posts and Telecommunications), Wan Yee Lau(Chinese University of Hong Kong)
Cited by 227
Related Papers
Laparoscopic resection of rectosigmoid carcinoma: prospective randomised trial
|The Lancet|2004|895
A Randomized Phase III Study of Doxorubicin Versus Cisplatin/Interferon α-2b/Doxorubicin/Fluorouracil (PIAF) Combination Chemotherapy for Unresectable Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2005|591
Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients.
|PubMed|1999|519
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
|Journal of Hepatology|2014|335
Systemic Cytokine Response After Laparoscopic-Assisted Resection of Rectosigmoid Carcinoma
|Annals of Surgery|2000|254